The goal of obesity management is to improve health. Sustained weight loss of more
than 10% overall bodyweight improves many of the complications associated with obesity
(eg, prevention and control of type 2 diabetes, hypertension, fatty liver disease,
and obstructive sleep apnoea), as well as quality of life. Maintenance of weight loss
is the major challenge of obesity management. Like all chronic diseases, managing
obesity requires a long-term, multimodal approach, taking into account each individual's
treatment goals, and the benefit and risk of different therapies.

Related Keywords

Mexico , Australia , United States , Copenhagen , Køavn , Denmark , Catal , Departamento De Cabanas , El Salvador , Poitou , France General , France , Saudi Arabia , Sweden , Jannah , Al Qasim , South Korea , Australian , Saudi , Swedish , Han , French , American , Salvador , Al Tikriti , Abu Dayyeh , Gastrointest Endosc , Tiel Ansari , J Clin Nutr , Coll Cardiol , J Clin Endocrinol , Clin Nutr , Regional Office For Europe , International Federation For The Surgery Of Obesity , Obesity Society , Lancet Reg Health , American Association Of Clinical Endocrinologists , Group On Visceral Obesity , European Association For Endoscopic Surgery , Englj Med , Regional Obesity Report , Obes Metab , Intern Med , American College , American Heart Association Task Force , Practice Guidelines , Clinical Endocrinologists , European Association , Endoscopic Surgery , Australian Obesity Management Algorithm , Res Clin Pract , Pharmacol Ther , Rev Drug Discov , Diabetes Endocrinol , Obes Relat Dis , Opin Psychiatry , Sci Pract , Opin Gastroenterol , Clin Med , Rev Endocrinol Metab , Swedish Obese Subjects , Consensus Statement , Rev Endocrinol , Obes Rep , White Caucasians , Clin Endocrinol Metab , Clin Pharmacol Toxicol ,